-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $89

Benzinga·08/20/2026 10:25:07
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $39 to $89.